Metabolon Announces Quantose IR Test Launched In Mexico To Help Prevent Type 2 Diabetes
6/5/2014 9:04:03 AM
RESEARCH TRIANGLE PARK, N.C., June 4, 2014 (GLOBE NEWSWIRE) -- Metabolon, a global leader in metabolomics, announced today that its Quantose IR™ prediabetes test is now available to physicians in Mexico through PATIA Biopharma, its commercial partner there. In addition, PATIA and its affiliates will be using Quantose IR in two large-scale studies to test up to three million adults and teenagers in Mexico who are overweight or obese and/or have a family history of diabetes. It is estimated that one out of every five adults in Mexico has prediabetes, a condition that often progresses to type 2 diabetes if left untreated. Early detection is crucial, because prediabetes can be reversed with lifestyle changes and treatment.
Help employers find you! Check out all the jobs and post your resume.
comments powered by